Diagnostic and prognostic molecular markers in renal cell carcinoma

The Journal of Urology
Hari S G R Tunuguntla, Merce Jorda

Abstract

We reviewed the contemporary literature on molecular biomarkers in renal cell carcinoma and their prognostic significance. Articles published during 1981 to 2007 in English on renal cell carcinoma were surveyed using the MEDLINE/PubMed database. The subject headings included were genetics, biomarkers, prognosis and risk models of renal cell carcinoma. We present a synthesis of currently known renal cell carcinoma biomarkers at various stages of development and their clinical significance, and prognostic nomograms incorporating biomarkers. The beneficiary role of biomarkers in renal cell carcinoma is challenged by the relatively low prevalence of the disease. Even if a biomarker for renal cell carcinoma had 100% sensitivity and 99.4% specificity, the positive predictive value of the marker in men older than 65 years would be only 10%. Several biomarkers are being investigated in renal cell carcinoma, of which many relate to pathogenic molecular changes that are currently therapeutic targets. Carbonic anhydrase IX is a von Hippel-Lindau mediated enzyme that is expressed in most renal cell carcinoma cases. High (greater than 85%) expression of this marker indicates favorable prognosis and may predict the response to interleukin-2 ...Continue Reading

References

Apr 1, 1989·The Journal of Urology·M TakashiK Kato
Oct 13, 1983·The New England Journal of Medicine·R C BastR C Knapp
Sep 1, 1982·Journal of Clinical Pathology·G J MuftiJ Stevens
Jan 1, 1995·European Urology·P MeriaA Le Duc
Sep 19, 1996·The New England Journal of Medicine·R J MotzerD M Nanus
Jun 15, 1999·BJU International·Y MurakamiS Kagawa
Jul 17, 1999·British Journal of Cancer·L FumagalliF Rovelli
Aug 1, 2000·Kidney International·C Westenfelder, R L Baranowski
May 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Farhang RabbaniPaul Russo
Sep 5, 2002·International Journal of Cancer. Journal International Du Cancer·Benedetta BussolatiGiovanni Camussi
Sep 19, 2002·American Journal of Obstetrics and Gynecology·Yoshio YoneyamaTsutomu Araki
Feb 5, 2003·Urologia Internationalis·A HegeleR Hofmann
Feb 11, 2003·The Journal of Urology·Arnaud MéjeanNicolas Thiounn
May 20, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Y MizutaniT Miki
Jul 29, 2003·Journal of Cancer Research and Clinical Oncology·Marijeta Kralj, Jasminka Pavelić
Jan 22, 2004·Clinica Chimica Acta; International Journal of Clinical Chemistry·Pranab Dey
Dec 4, 2004·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Shih-Ming Jung, Tseng-tong Kuo
Sep 30, 2005·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·M K KashyapS K Upadhyaya
Mar 4, 2006·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Aug 15, 2006·Current Opinion in Urology·Brian I Rini

❮ Previous
Next ❯

Citations

May 10, 2011·Analytical and Bioanalytical Chemistry·Satoru MinamidaShiro Baba
Oct 16, 2010·Current Urology Reports·Rou WangDavid P Wood
Mar 15, 2011·Journal of Medicinal Chemistry·Pavel MaderPavlína Řezáčová
Mar 1, 2010·Therapeutic Advances in Medical Oncology·Sunali MehtaCristin Print
Nov 11, 2011·Journal of Experimental & Clinical Cancer Research : CR·Xiangan TuYuanyuan Zhang
Dec 21, 2010·International Journal of Urology : Official Journal of the Japanese Urological Association·Mototsugu MuramakiMasato Fujisawa
Mar 13, 2014·Journal of Experimental & Clinical Cancer Research : CR·Jintao ZhuangShaopeng Qiu
Nov 6, 2014·Virchows Archiv : an International Journal of Pathology·Laura ZaldumbideJosé I López
Aug 5, 2016·British Journal of Cancer·Basma Greef, Tim Eisen
Sep 24, 2013·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Marcelo ZeratiMarcos Francisco Dall'Oglio
Dec 3, 2014·Urologia·Giuseppe LucarelliMichele Battaglia

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis